Big small company’s strategy off to a good start
We have spent the first six months of the year implementing our new strategy: refining it during the first quarter and communicating and launching its implementation during the second quarter. Second quarter net sales decreased to EUR 54.4 (57.3) million, representing a decline of 4.8%, but comparable EBIT increased to EUR 7.9 (7.4) million, representing an increase of 6.3% compared to the comparison period. Our market performance has been very mixed. Consumer brand volumes developed positively, growing by 4.8% in volume and 1.6% in sales value, but industrial sales volumes declined by 12.9% and sales value by 16.6%. Consumer brands accounted for approximately 70% of our net sales, so the significant decline in industrial sales translated into a moderate decline in the Group’s net sales during the reporting period.
The implementation of our strategy, presented at the Capital Markets Day at the end of May 2025, has started as planned. At the end of March, we divested our plant protein business. This will allow us to better focus on breakfast and snacking products, heart health products and the development of new business. The impact of the divestment was EUR -1.1 million on comparable net sales and EUR +0.6 million on comparable EBIT in the second quarter.
The most significant change in the second quarter was the reorganisation of our business areas. This has allowed us to create clear and focused responsibilities, allocate our resources more effectively to implement our strategy and improve our cost efficiency. We appointed directors responsible for each business area. To accelerate structural growth, our Board of Directors established a special M&A Committee and we recruited a new M&A Director.
Our operations are international, and half of our net sales come from outside Finland. In April, we continued our geographical expansion with the launch of Elovena® in Spain. In line with our new strategy, we are now expanding geographically into a number of carefully selected markets, where we operate using a leaner model based on local partnerships. This increases flexibility and speed while reducing our risks. At the same time, the economic impact of opening up each new market is smaller in the short term. We will continue to develop our expansion model to make our growth faster, more resource-efficient and more repeatable.
Despite the positive development in earnings, we cannot be satisfied with the sales development in the second quarter. Consumer sales of our main brands developed well in all our main markets, but domestic industrial sales in the Breakfast, Snacking & Food Solutions segment in particular were below last year’s level. This was due to intense price competition in the market, which requires us to make our operations even more efficient. The Heart Health segment was more stable, with the decline in net sales in the second quarter being a natural consequence of deliveries to industrial customers exceeding normal levels in the first quarter.
In line with the objectives and plan for this strategy period, which emphasised improving profitability at the beginning of the period, our earnings have developed faster than our sales during the first half of the year. In the long run, however, accelerating organic growth is critical. Improved margins through streamlined operations will enable either greater marketing investments or more aggressive pricing, depending on market demand. This means that by improving our earnings and efficiency, we are laying the foundation for faster growth. Once the foundation is in place, we can shift our focus more strongly towards accelerating growth.
Responsibility work is also about risk management and new business opportunities
Solving our common problems not only secures our operating conditions, but also creates new business opportunities. Alongside climate change, biodiversity loss is one of the greatest challenges facing humanity. Therefore, we have begun mapping the agricultural biodiversity of our contract farms in connection with our carbon footprint calculations.
Similarly, excess weight and obesity are among the greatest health challenges of our time. The prevention and effective treatment of obesity require broad-based cooperation. As the only food company, Raisio was involved in establishing a new, cross-sector network for the prevention and treatment of obesity. A diet rich in fibre supports weight management and reduces the risk of cardiovascular diseases. This is why we are investing in fibre, both in our current product range and in our research and development work aimed at new business opportunities.
Pasi Flinkman
CEO, Raisio plc
August 2025
Half-Year Financial Report January-June 2025